MyDosageBeta
Canonical · evidence-anchored

GH-axis recomp (ipamorelin + CJC-1295)

Observed protocol pattern: pulsatile GH support for lean-mass preservation under caloric deficit.

12 weeks3 variantsobservational4 evidence nodes
Outcomes this template targets
  • Lean mass preservation
    Weight 100%
  • Body composition improvement
    Weight 85%
  • Muscle retention
    Weight 80%
  • Lean mass gain
    Weight 75%
  • Body fat reduction
    Weight 50%
Pick a variant

Same template. Three intensities.

Gentle, Balanced, Advanced. We adjust dose curve, ramp, monitoring and check-in cadence — the science pattern stays identical.

Stack at balanced

Doses adjust with the variant.

  1. 01
    cjc-1295
    Pair with ipamorelin.
    100 mcg
    5x weekly pre-bed
  2. 02
    ipamorelin
    Empty stomach, 2h post-meal.
    200 mcg
    5x weekly pre-bed
Monitor
  • — fasting glucose
  • — HbA1c at 12 weeks
  • — body composition
  • — sleep
Stop rules
  • — fasting glucose drift >15%
  • — persistent edema
  • — no measurable composition change by week 12
Ready to run this?

Start a journey at the Balanced variant.

Begin onboarding